Many studies have provided observational data on the association of obesity and thyroid cancers, but only few of them propose mechanisms that would permit a better understanding of the causal molecular mechanisms of this association. Considering that there is an increasing incidence of both obesity and thyroid cancers, we need to summarize and link recent studies in order to characterize and understand the contribution of obesity-related factors that might affect thyroid cancer development and progression. Adipose tissue is involved in many vital processes, including insulin sensitivity, angiogenesis, regulation of energy balance, activation of the complement system, and responses such as inflammation. Although these processes have their own molecular pathways, they involve the same molecules through which obesity and adipose tissue might exert their roles in carcinogenesis, not only affecting MAPK and PI3K or even insulin pathways, but also recruiting local inflammatory responses that could result in disease formation and progression. This review describes five important issues that might explain the link between excessive weight and thyroid cancer: thyroid hormones, insulin resistance, adipokines, inflammation, and sexual hormones.215T255T271Agate, L., Lorusso, L., Elisei, R., New and old knowledge on differentiated thyroid cancer epidemiology and risk factors (2012) Journal of Endocrinological Investigation, 35, pp. 3-9Akinci, M., Kosova, F., Cetin, B., Aslan, S., Ari, Z., Cetin, A., Leptin levels in thyroid cancer (2009) Asian Journal of Surgery, 32, pp. 216-223Albanes, D., Caloric intake, body weight, and cancer: A review (1987) Nutrition and Cancer, 9, pp. 199-217Alevizaki, M., Saltiki, K., Voidonikola, P., Mantzou, E., Papamichael, C., Stamatelopoulos, K., Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals (2009) European Journal of Endocrinology, 161, pp. 459-465Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M.T., Ventura, V., Foti, D., Brunetti, A., Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms (2012) Experimental Diabetes Research, 2012, p. 789174Artim, S.C., Mendrola, J.M., Lemmon, M.A., Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family (2012) Biochemical Journal, 448, pp. 213-220Ayturk, S., Gursoy, A., Kut, A., Anil, C., Nar, A., Tutuncu, N.B., Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area (2009) European Journal of Endocrinology, 161, pp. 599-605Balkan, F., Onal, E.D., Usluogullari, A., Tuzun, D., Ozdemir, D., Inancli, S.S., Ersoy, R., Cakir, B., Is there any association between insulin resistance and thyroid cancer?: A case control study (2014) Endocrine, 45, pp. 55-60Banu, K.S., Govindarajulu, P., Aruldhas, M.M., Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action (2001) Endocrine Pathology, 12, pp. 315-327Begg, L., Kuller, L.H., Gutai, J.P., Caggiula, A.G., Wolmark, N., Watson, C.G., Endogenous sex hormone levels and breast cancer risk (1987) Genetic Epidemiology, 4, pp. 233-247Benomar, Y., Gertler, A., De Lacy, P., Crepin, D., Hamouda, H.O., Riffault, L., Taouis, M., Central resistin overexposure induces insulin resistance through toll-like receptor 4 (2013) Diabetes, 62, pp. 102-114Li, S., Shin, H.J., Ding, E.L., Van Dam, R.M., Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis (2009) Journal of the American Medical Association, 302, pp. 179-188Li, Y., Zhang, J., Ma, H., Chronic inflammation and gallbladder cancer (2013) Cancer Letters, 345, pp. 242-248Liu, Z., Brooks, R.S., Ciappio, E.D., Kim, S.J., Crott, J.W., Bennett, G., Greenberg, A.S., Mason, J.B., Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: A mechanism for obesity-associated colorectal cancer (2012) Journal of Nutritional Biochemistry, 23, pp. 1207-1213Lodh, M., Goswami, B., Gupta, N., Patra, S.K., Saxena, A., Assessment of oxidative stress and inflammatory process in patients of multiple myeloma (2012) Indian Journal of Clinical Biochemistry, 27, pp. 410-413Longo, V.D., Finch, C.E., Evolutionary medicine: From dwarf model systems to healthy centenarians? (2003) Science, 299, pp. 1342-1346Lumachi, F., Basso, S.M., Orlando, R., Cytokines, thyroid diseases and thyroid cancer (2010) Cytokine, 50, pp. 229-233Manji, N., Boelaert, K., Sheppard, M.C., Holder, R.L., Gough, S.C., Franklyn, J.A., Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects (2006) Clinical Endocrinology, 64, pp. 125-128Marcello, M.A., Sampaio, A.C., Geloneze, B., Vasques, A.C., Assumpcao, L.V., Ward, L.S., Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer (2012) Nutrition and Cancer, 64, pp. 1190-1195Marcello, M.A., Araujo, P., Calixto, A., Vasques, A.J., Tincani, A.J., Geloneze, B., Ward, L.S., Serum adiponectin and ghrelin levels may help to identify malignancy in thyroid nodules (2012) 82nd American Thyroid Association Annual Meeting, , Ed ATA. Québec City, Canada: Mary Ann Liebert, IncMcLeod, D.S., Cooper, D.S., Ladenson, P.W., Ain, K.B., Brierley, J.D., Fein, H.G., Haugen, B.R., Ross, D.S., Prognosis of differentiated thyroid cancer in relation to serum TSH and thyroglobulin antibody status at time of diagnosis (2013) Thyroid, 24, pp. 35-42Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., Tarkowski, A., Resistin, an adipokine with potent proinflammatory properties (2005) Journal of Immunology, 174, pp. 5789-5795McTiernan, A.M., Weiss, N.S., Daling, J.R., Incidence of thyroid cancer in women in relation to reproductive and hormonal factors (1984) American Journal of Epidemiology, 120, pp. 423-435Menendez, C., Baldelli, R., Camina, J.P., Escudero, B., Peino, R., Dieguez, C., Casanueva, F.F., TSH stimulates leptin secretion by a direct effect on adipocytes (2003) Journal of Endocrinology, 176, pp. 7-12Mijovic, T., How, J., Pakdaman, M., Rochon, L., Gologan, O., Hier, M.P., Black, M.J., Payne, R.J., Body mass index in the evaluation of thyroid cancer risk (2009) Thyroid, 19, pp. 467-472Mitsiades, N., Pazaitou-Panayiotou, K., Aronis, K.N., Moon, H.S., Chamberland, J.P., Liu, X., Diakopoulos, K.N., Mylvaganam, G., Circulating adiponectin is inversely associated with risk of thyroid cancer: In vivo and in vitro studies (2011) Journal of Clinical Endocrinology and Metabolism, 96, pp. E2023-E2028Nannipieri, M., Cecchetti, F., Anselmino, M., Camastra, S., Niccolini, P., Lamacchia, M., Rossi, M., Ferrannini, E., Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: Effects of weight loss (2009) International Journal of Obesity, 33, pp. 1001-1006Obeid, S., Hebbard, L., Role of adiponectin and its receptors in cancer (2012) Cancer Biology & Medicine, 9, pp. 213-220Ock, S., Ahn, J., Lee, S.H., Kang, H., Offermanns, S., Ahn, H.Y., Jo, Y.S., Jo, D., IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter (2013) FASEB Journal, 27, pp. 4899-4908Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., Prevalence of overweight and obesity in the United States, 1999-2004 (2006) Journal of the American Medical Association, 295, pp. 1549-1555Oge, A., Bayraktar, F., Saygili, F., Guney, E., Demir, S., TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients (2005) Endocrine Journal, 52, pp. 213-217Pang, X.P., Yoshimura, M., Wang, J., Dubinett, S.M., TNF-α-induced antiproliferation is not dependent on the autocrine action of TGF-β 1 in a thyroid cancer cell line (1994) Lymphokine and Cytokine Research, 13, pp. 93-97Boru, C., Silecchia, G., Pecchia, A., Iacobellis, G., Greco, F., Rizzello, M., Basso, N., Prevalence of cancer in Italian obese patients referred for bariatric surgery (2005) Obesity Surgery, 15, pp. 1171-1176Pang, X.P., Ross, N.S., Hershman, J.M., Alterations in TNF-α signal transduction in resistant human papillary thyroid carcinoma cells (1996) Thyroid, 6, pp. 313-317Pappa, T., Alevizaki, M., Obesity and thyroid cancer: A clinical update (2013) Thyroid, 24, pp. 190-199Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., Vigneri, R., Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors (2013) Journal of Cancer Epidemiology, 2013, p. 965212Perez Rodrigo, C., Current mapping of obesity (2013) Nutrición Hospitalaria, 28, pp. 21-31Piya, M.K., McTernan, P.G., Kumar, S., Adipokine inflammation and insulin resistance: The role of glucose, lipids and endotoxin (2013) Journal of Endocrinology, 216, pp. T1-T15Qiu, J., Yang, R., Rao, Y., Du, Y., Kalembo, F.W., Risk factors for breast cancer and expression of insulin-like growth factor-2 (IGF-2) in women with breast cancer in Wuhan City, China (2012) PLoS ONE, 7Rajoria, S., Suriano, R., Shanmugam, A., Wilson, Y.L., Schantz, S.P., Geliebter, J., Tiwari, R.K., Metastatic phenotype is regulated by estrogen in thyroid cells (2010) Thyroid, 20, pp. 33-41Ranks, J.B., Feliciano, D., Kansakar, E., Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer (2009) American Surgeon, 75, pp. 785-789. , discussion 789Rapp, K., Schroeder, J., Klenk, J., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., Weiland, S.K., Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria (2006) Diabetologia, 49, pp. 945-952Reinehr, T., Obesity and thyroid function (2010) Molecular and Cellular Endocrinology, 316, pp. 165-171Brindel, P., Doyon, F., Rachedi, F., Boissin, J.L., Sebbag, J., Shan, L., Chungue, V., Paoaafaite, J., Anthropometric factors in differentiated thyroid cancer in French Polynesia: A case-control study (2009) Cancer Causes & Control, 20, pp. 581-590Reinehr, T., De Sousa, G., Andler, W., Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids (2006) Journal of Clinical Endocrinology and Metabolism, 91, pp. 3088-3091Rendina, D., De Filippo, G., Mossetti, G., Zampa, G., Muscariello, R., Benvenuto, G., Vivona, C.L., Lombardi, G., Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency (2012) Journal of Endocrinological Investigation, 35, pp. 407-412Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies (2008) Lancet, 371, pp. 569-578Rezzonico, J., Rezzonico, M., Pusiol, E., Pitoia, F., Niepomniszcze, H., Introducing the thyroid gland as another victim of the insulin resistance syndrome (2008) Thyroid, 18, pp. 461-464Rezzonico, J.N., Rezzonico, M., Pusiol, E., Pitoia, F., Niepomniszcze, H., Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma (2009) Metabolic Syndrome and Related Disorders, 7, pp. 375-380Rezzonico, J., Rezzonico, M., Pusiol, E., Pitoia, F., Niepomniszcze, H., Metformin treatment for small benign thyroid nodules in patients with insulin resistance (2011) Metabolic Syndrome and Related Disorders, 9, pp. 69-75Rinaldi, S., Lise, M., Clavel-Chapelon, F., Boutron-Ruault, M.C., Guillas, G., Overvad, K., Tjonneland, A., Kaaks, R., Body size and risk of differentiated thyroid carcinomas: Findings from the EPIC study (2012) International Journal of Cancer, 131, pp. E1004-E1014Rivas, M., Santisteban, P., TSH-activated signaling pathways in thyroid tumorigenesis (2003) Molecular and Cellular Endocrinology, 213, pp. 31-45Ron, E., Kleinerman, R.A., Boice, J.D., Jr., LiVolsi, V.A., Flannery, J.T., Fraumeni, J.F., Jr., A population-based case-control study of thyroid cancer (1987) Journal of the National Cancer Institute, 79, pp. 1-12Rosenbaum, M., Hirsch, J., Murphy, E., Leibel, R.L., Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function (2000) American Journal of Clinical Nutrition, 71, pp. 1421-1432Brito, J.P., Morris, J.C., Montori, V.M., Too much medicine. Thyroid cancer: Zealous imaging has increased detection and treatment of low risk tumours (2013) BMJ, 347Samanic, C., Gridley, G., Chow, W.H., Lubin, J., Hoover, R.N., Fraumeni, J.F., Jr., Obesity and cancer risk among white and black United States veterans (2004) Cancer Causes & Control, 15, pp. 35-43Santini, F., Galli, G., Maffei, M., Fierabracci, P., Pelosini, C., Marsili, A., Giannetti, M., Molinaro, E., Acute exogenous TSH administration stimulates leptin secretion in vivo (2010) European Journal of Endocrinology, 163, pp. 63-67Sari, R., Balci, M.K., Altunbas, H., Karayalcin, U., The effect of body weight and weight loss on thyroid volume and function in obese women (2003) Clinical Endocrinology, 59, pp. 258-262Schaffler, A., Scholmerich, J., Innate immunity and adipose tissue biology (2010) Trends in Immunology, 31, pp. 228-235Shah, S.H., Imbalance diet: A risk factor for thyroid cancer (1999) Journal of the Pakistan Medical Association, 49, p. 130Shih, S.R., Chiu, W.Y., Chang, T.C., Tseng, C.H., Diabetes and thyroid cancer risk: Literature review (2012) Experimental Diabetes Research, 2012, p. 578285Sprague, B.L., Andersen, S.W., Trentham-Dietz, A., Thyroid cancer incidence and socioeconomic indicators of health care access (2008) Cancer Causes & Control, 19, pp. 585-593Steppan, C.M., Wang, J., Whiteman, E.L., Birnbaum, M.J., Lazar, M.A., Activation of SOCS-3 by resistin (2005) Molecular and Cellular Biology, 25, pp. 1569-1575Stewart, P.A., Luks, J., Roycik, M.D., Sang, Q.X., Zhang, J., Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer (2013) PLoS ONE, 8Strong, A.L., Strong, T.A., Rhodes, L.V., Semon, J.A., Zhang, X., Shi, Z., Zhang, S., Bunnell, B.A., Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways (2013) Breast Cancer Research, 15, p. R102Cady, B., Sedgwick, C.E., Meissner, W.A., Wool, M.S., Salzman, F.A., Werber, J., Risk factor analysis in differentiated thyroid cancer (1979) Cancer, 43, pp. 810-820Sun, A., Liu, R., Sun, G., Insulin therapy and risk of colorectal cancer: An updated meta-analysis of epidemiological studies (2013) Current Medical Research and Opinion, 30, pp. 423-430Surmacz, E., Leptin and adiponectin: Emerging therapeutic targets in breast cancer (2013) Journal of Mammary Gland Biology and Neoplasia, 18, pp. 321-332Takada, K., Amino, N., Tada, H., Miyai, K., Relationship between proliferation and cell cycle-dependent Ca2+ influx induced by a combination of thyrotropin and insulin-like growth factor-I in rat thyroid cells (1990) Journal of Clinical Investigation, 86, pp. 1548-1555Takemura, Y., Ouchi, N., Shibata, R., Aprahamian, T., Kirber, M.T., Summer, R.S., Kihara, S., Walsh, K., Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies (2007) Journal of Clinical Investigation, 117, pp. 375-386Tangjitgamol, S., Ramirez, P.T., Sun, C.C., See, H.T., Jhingran, A., Kavanagh, J.J., Deavers, M.T., Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of tCappelli, C., Pirola, I., Mittempergher, F., De Martino, E., Casella, C., Agosti, B., Nascimbeni, R., Castellano, M., Morbid obesity in women is associated to a lower prevalence of thyroid nodules (2012) Obesity Surgery, 22, pp. 460-464Catalan, V., Gomez-Ambrosi, J., Rodriguez, A., Fruhbeck, G., Adipose tissue immunity and cancer (2013) Frontiers in Physiology, 4, p. 275Chang, J.W., Yeh, K.Y., Shen, Y.C., Hsieh, J.J., Chuang, C.K., Liao, S.K., Tsai, L.H., Wang, C.H., Production of multiple cytokines and induction of cachexia in athymic nude mice by a new anaplastic thyroid carcinoma cell line (2003) Journal of Endocrinology, 179, pp. 387-394Chen, G.G., Vlantis, A.C., Zeng, Q., Van Hasselt, C.A., Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer (2008) Current Cancer Drug Targets, 8, pp. 367-377Chen, A.Y., Jemal, A., Ward, E.M., Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005 (2009) Cancer, 115, pp. 3801-3807Cheng, I., Stram, D.O., Burtt, N.P., Gianniny, L., Garcia, R.R., Pooler, L., Henderson, B.E., Haiman, C.A., IGF2R missense single-nucleotide polymorphisms and breast cancer risk: The multi-ethnic cohort study (2009) Cancer Epidemiology, Biomarkers & Prevention, 18, pp. 1922-1924Cheng, S.P., Yin, P.H., Chang, Y.C., Lee, C.H., Huang, S.Y., Chi, C.W., Differential roles of leptin in regulating cell migration in thyroid cancer cells (2010) Oncology Reports, 23, pp. 1721-1727Cheng, S.P., Chi, C.W., Tzen, C.Y., Yang, T.L., Lee, J.J., Liu, T.P., Liu, C.L., Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma (2010) Surgery, 147, pp. 847-853Cheng, S.P., Yin, P.H., Hsu, Y.C., Chang, Y.C., Huang, S.Y., Lee, J.J., Chi, C.W., Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways (2011) Oncology Reports, 26, pp. 1265-1271Cheng, S.P., Liu, C.L., Hsu, Y.C., Chang, Y.C., Huang, S.Y., Lee, J.J., Regulation of leptin receptor expression in human papillary thyroid cancer cells (2012) Biomedicine & Pharmacotherapy, 66, pp. 469-473Cheng, S.P., Liu, C.L., Hsu, Y.C., Chang, Y.C., Huang, S.Y., Lee, J.J., Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma (2013) Cell Biochemistry and Biophysics, 65, pp. 203-210Cheung, N.W., Boyages, S.C., The thyroid gland in acromegaly: An ultrasonographic study (1997) Clinical Endocrinology, 46, pp. 545-549Chu, R., Van Hasselt, A., Vlantis, A.C., Ng, E.K., Liu, S.Y., Fan, M.D., Ng, S.K., Li, X.Y., The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor γ in thyroid cancer (2013) Cancer, 120, pp. 142-153Clement, S., Refetoff, S., Robaye, B., Dumont, J.E., Schurmans, S., Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-I receptor in the thyroid gland (2001) Endocrinology, 142, pp. 5131-5139Clero, E., Leux, C., Brindel, P., Truong, T., Anger, A., Teinturier, C., Diallo, I., De Vathaire, F., Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: The importance of body surface area (2010) Thyroid, 20, pp. 1285-1293Couto, J.P., Daly, L., Almeida, A., Knauf, J.A., Fagin, J.A., Sobrinho-Simoes, M., Lima, J., Lyden, D., STAT3 negatively regulates thyroid tumorigenesis (2012) PNAS, 109, pp. E2361-E2370Cunha, L.L., Marcello, M.A., Ward, L.S., The role of the inflammatory microenvironment in thyroid carcinogenesis (2014) Endocrine-Related Cancer, 21, pp. R85-R103Dalamaga, M., Sotiropoulos, G., Karmaniolas, K., Pelekanos, N., Papadavid, E., Lekka, A., Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory andmetabolic parameters (2013) Clinical Biochemistry, 46, pp. 584-590Dal Maso, L., La Vecchia, C., Franceschi, S., Preston-Martin, S., Ron, E., Levi, F., Mack, W., Kolonel, L., A pooled analysis of thyroid cancer studies. V. Anthropometric factors (2000) Cancer Causes & Control, 11, pp. 137-144Davies, L., Welch, H.G., Increasing incidence of thyroid cancer in the United States, 1973-2002 (2006) Journal of the American Medical Association, 295, pp. 2164-2167De Pergola, G., Ciampolillo, A., Paolotti, S., Trerotoli, P., Giorgino, R., Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women (2007) Clinical Endocrinology, 67, pp. 265-269De Pergola, G., Nardecchia, A., Giagulli, V.A., Triggiani, V., Guastamacchia, E., Minischetti, M.C., Silvestris, F., Obesity and heart failure (2013) Endocrine, Metabolic & Immune Disorders Drug Targets, 13, pp. 51-57Di Cristofano, A., Obesity and thyroid cancer: Is leptin the (only) link? (2013) Endocrinology, 154, pp. 2567-2569Dimitriadis, G., Maratou, E., Boutati, E., Kollias, A., Tsegka, K., Alevizaki, M., Peppa, M., Hadjidakis, D.J., IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism (2008) European Journal of Endocrinology, 158, pp. 361-366Di Vito, M., De Santis, E., Perrone, G.A., Mari, E., Giordano, M.C., De Antoni, E., Coppola, L., Carpi, A., Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser-capture microdissection and molecular biology (2011) Cancer Science, 102, pp. 1921-1927Djiogue, S., Nwabo Kamdje, A.H., Vecchio, L., Kipanyula, M.J., Farahna, M., Aldebasi, Y., Seke Etet, P.F., Insulin resistance and cancer: The role of insulin and IGFs (2013) Endocrine-Related Cancer, 20, pp. R1-R17Duan, X.F., Tang, P., Li, Q., Yu, Z.T., Obesity, adipokines and hepatocellular carcinoma (2013) International Journal of Cancer, 133, pp. 1776-1783Dutta, D., Ghosh, S., Pandit, K., Mukhopadhyay, P., Chowdhury, S., Leptin and cancer: Pathogenesis and modulation (2012) Indian Journal of Endocrinology and Metabolism, 16, pp. S596-S600Eggo, M.C., Bachrach, L.K., Burrow, G.N., Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function (1990) Growth Factors, 2, pp. 99-109Enewold, L., Zhu, K., Ron, E., Marrogi, A.J., Stojadinovic, A., Peoples, G.E., Devesa, S.S., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 (2009) Cancer Epidemiology, Biomarkers & Prevention, 18, pp. 784-791Engeland, A., Tretli, S., Akslen, L.A., Bjorge, T., Body size and thyroid cancer in two million Norwegian men and women (2006) British Journal of Cancer, 95, pp. 366-370Farid, N.R., Shi, Y., Zou, M., Molecular basis of thyroid cancer (1994) Endocrine Reviews, 15, pp. 202-232Feldt-Rasmussen, U., Thyroid and leptin (2007) Thyroid, 17, pp. 413-419Fiore, E., Vitti, P., Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease (2012) Journal of Clinical Endocrinology and Metabolism, 97, pp. 1134-1145Flegal, K.M., Carroll, M.D., Kit, B.K., Ogden, C.L., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 (2012) Journal of the American Medical Association, 307, pp. 491-497Ford, E.S., Mokdad, A.H., Giles, W.H., Trends in waist circumference among US adults (2003) Obesity Research, 11, pp. 1223-1231Fox, C.S., Pencina, M.J., D'Agostino, R.B., Murabito, J.M., Seely, E.W., Pearce, E.N., Vasan, R.S., Relations of thyroid function to body weight: Cross-sectional and longitudinal observations in a community-based sample (2008) Archives of Internal Medicine, 168, pp. 587-592Franceschi, S., Talamini, R., Fassina, A., Bidoli, E., Diet and epithelial cancer of the thyroid gland (1990) Tumori, 76, pp. 331-338Franceschi, S., Levi, F., Negri, E., Fassina, A., La Vecchia, C., Diet and thyroid cancer: A pooled analysis of four European case-control studies (1991) International Journal of Cancer, 48, pp. 395-398Fruhbeck, G., Intracellular signalling pathways activated by leptin (2006) Biochemical Journal, 393, pp. 7-20Galanti, M.R., Hansson, L., Lund, E., Bergstrom, R., Grimelius, L., Stalsberg, H., Carlsen, E., Ekbom, A., Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: A population-based case-control study (1996) Cancer Epidemiology, Biomarkers & Prevention, 5, pp. 425-431Ghosh, S., Ashcraft, K., An IL-6 link between obesity and cancer (2013) Frontiers in Bioscience, 5, pp. 461-478Gordon, S., Taylor, P.R., Monocyte and macrophage heterogeneity (2005) Nature Reviews. Immunology, 5, pp. 953-964Grodski, S., Brown, T., Sidhu, S., Gill, A., Robinson, B., Learoyd, D., Sywak, M., Delbridge, L., Increasing incidence of thyroid cancer is due to increased pathologic detection (2008) Surgery, 144, pp. 1038-1043Gunter, M.J., Hoover, D.R., Yu, H., Wassertheil-Smoller, S., Rohan, T.E., Manson, J.E., Howard, B.V., Ho, G.Y., Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women (2008) Cancer Research, 68, pp. 329-337Guo, S., Insulin signaling, resistance, and the metabolic syndrome: Insights from mouse models to disease mechanisms (2013) Journal of Endocrinology, 220, pp. T1-T23Haddad, F.H., Malkawi, O.M., Omari, A.A., Izzat, A.S., Khassrof, H.M., Faiad, L.M., Okla, A.L., Jamil, A.N., Diabetes and infarcted papillary thyroid cancer (2002) Saudi Medical Journal, 23, pp. 467-470Hall, J., Roberts, R., Vora, N., Energy homoeostasis: The roles of adipose tissue-derived hormones, peptide YY and ghrelin (2009) Obesity Facts, 2, pp. 117-125Han, J.M., Kim, T.Y., Jeon, M.J., Yim, J.H., Kim, W.G., Song, D.E., Hong, S.J., Shin, M.H., Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population (2013) European Journal of Endocrinology, 168, pp. 879-886Hard, G.C., Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis (1998) Environmental Health Perspectives, 106, pp. 427-436Hlavna, M., Kohut, L., Lipkova, J., Bienertova-Vasku, J., Dostalova, Z., Chovanec, J., Vasku, A., Relationship of resistin levels with endometrial cancer risk (2011) Neoplasma, 58, pp. 124-128Hursting, S.D., Lashinger, L.M., Wheatley, K.W., Rogers, C.J., Colbert, L.H., Nunez, N.P., Perkins, S.N., Reducing the weight of cancer: Mechanistic targets for breaking the obesity-carcinogenesis link (2008) Best Practice & Research. Clinical Endocrinology & Metabolism, 22, pp. 659-669Hvidtfeldt, U.A., Gunter, M.J., Lange, T., Chlebowski, R.T., Lane, D., Farhat, G.N., Freiberg, M.S., Prentice, R., Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer (2012) Cancer Epidemiology, Biomarkers & Prevention, 21, pp. 1203-1212IARC, (2002) Weight Control and Physical Activity, , Lyon: IARC PressINCA M, (2014) Estimativa 2014 - Incidência de Câncer no Brasil, , http://www.slideshare.net/MinSaude/estimativa-cancer2014, Rio de Janeiro: MS/INCAInoue, M., Tsugane, S., Insulin resistance and cancer: Epidemiological evidence (2012) Endocrine-Related Cancer, 19, pp. F1-F8Jiang, C.Y., Wang, W., Yin, Y.L., Yuan, Z.R., Wang, L.B., Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma (2012) Oncology Letters, 4, pp. 960-964Jung, C.K., Lubin, J.H., Brenner, A.V., Little, M.P., Sigurdson, A.J., Nikiforov, Y.E., The increase in papillary thyroid cancer incidence in the US during the last four decades is accompanied by a high and stable frequency of BRAF mutations and a sharp increase in NRAS mutations (2012) Modern Pathology, 25 (S2), p. 146AKaaks, R., Lukanova, A., Kurzer, M.S., Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review (2002) Cancer Epidemiology, Biomarkers & Prevention, 11, pp. 1531-1543Kamat, A., Rajoria, S., George, A., Suriano, R., Shanmugam, A., Megwalu, U., Prakash, P.B., Schantz, S., Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways (2011) Archives of Otolaryngology-Head & Neck Surgery, 137, pp. 1146-1153Kavanagh, D.O., McIlroy, M., Myers, E., Bane, F., Crotty, T.B., McDermott, E., Hill, A.D., Young, L.S., The role of oestrogen receptor α in human thyroid cancer: Contributions from coregulatory proteins and the tyrosine kinase receptor HER2 (2010) Endocrine-Related Cancer, 17, pp. 255-264Kavanagh, M.E., O'Sullivan, K.E., O'Hanlon, C., O'Sullivan, J.N., Lysaght, J., Reynolds, J.V., The esophagitis to adenocarcinoma sequenceThe role of inflammation (2013) Cancer Letters, 345, pp. 182-189Kern, M., Wells, J.A., Stephens, J.M., Elton, C.W., Friedman, J.E., Tapscott, E.B., Pekala, P.H., Dohm, G.L., Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level (1990) Biochemical Journal, 270, pp. 397-400Kim, H.J., Lee, Y.S., Won, E.H., Chang, I.H., Kim, T.H., Park, E.S., Kim, M.K., Myung, S.C., Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation (2011) BJU International, 108, pp. E77-E83Kim, H.J., Kim, N.K., Choi, J.H., Sohn, S.Y., Kim, S.W., Jin, S.M., Jang, H.W., Chung, J.H., Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer (2013) Clinical Endocrinology, 78, pp. 134-140Kim, W.G., Park, J.W., Willingham, M.C., Cheng, S.Y., Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model (2013) Endocrinology, 154, pp. 2936-2947Kim, M.R., Kim, S.S., Huh, J.E., Lee, B.J., Lee, J.C., Jeon, Y.K., Kim, B.H., Kim, Y.K., Neck circumference correlates with tumor size and lateral lymph node metastasis in men with small papillary thyroid carcinoma (2013) Korean Journal of Internal Medicine, 28, pp. 62-71Kimura, T., Van Keymeulen, A., Golstein, J., Fusco, A., Dumont, J.E., Roger, P.P., Regulation of thyroid cell proliferation by TSH and other factors: A critical evaluation of in vitro models (2001) Endocrine Reviews, 22, pp. 631-656Kintscher, U., Hartge, M., Hess, K., Foryst-Ludwig, A., Clemenz, M., Wabitsch, M., Fischer-Posovszky, P., Skurk, T., T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance (2008) Arteriosclerosis, Thrombosis, and Vascular Biology, 28, pp. 1304-1310Kitahara, C.M., Platz, E.A., Freeman, L.E., Hsing, A.W., Linet, M.S., Park, Y., Schairer, C., Berrington De Gonzalez, A., Obesity and thyroid cancer risk among U.S. Men and women: A pooled analysis of five prospective studies (2011) Cancer Epidemiology, Biomarkers & Prevention, 20, pp. 464-472Kitahara, C.M., Neta, G., Pfeiffer, R.M., Kwon, D., Xu, L., Freedman, N.D., Hutchinson, A.A., Sigurdson, A.J., Common obesity-related genetic variants and papillary thyroid cancer risk (2012) Cancer Epidemiology, Biomarkers & Prevention, 21, pp. 2268-2271Kitahara, C.M., Platz, E.A., Beane Freeman, L.E., Black, A., Hsing, A.W., Linet, M.S., Park, Y., Berrington De Gonzalez, A., Physical activity, diabetes, and thyroid cancer risk: A pooled analysis of five prospective studies (2012) Cancer Causes & Control, 23, pp. 463-471Kitahara, C.M., Platz, E.A., Park, Y., Hollenbeck, A.R., Schatzkin, A., Berrington De Gonzalez, A., Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study (2012) International Journal of Cancer, 130, pp. 1411-1419Knudsen, N., Laurberg, P., Rasmussen, L.B., Bulow, I., Perrild, H., Ovesen, L., Jorgensen, T., Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population (2005) Journal of Clinical Endocrinology and Metabolism, 90, pp. 4019-4024Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Maeda, N., Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages (2004) Circulation, 109, pp. 2046-2049Kumar, A., Klinge, C.M., Goldstein, R.E., Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors α and β (2010) International Journal of Oncology, 36, pp. 1067-1080Kuo, C.H., Chen, K.F., Chou, S.H., Huang, Y.F., Wu, C.Y., Cheng, D.E., Chen, Y.W., Huang, M.S., Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway (2013) Carcinogenesis, 34, pp. 2600-2609Kwon, H., Pessin, J.E., Adipokines mediate inflammation and insulin resistance (2013) Frontiers in Endocrinology, 4, p. 71Lassek, W.D., Gaulin, S.J., Changes in body fat distribution in relation to parity in American women: A covert form of maternal depletion (2006) American Journal of Physical Anthropology, 131, pp. 295-302Lee, M.L., Chen, G.G., Vlantis, A.C., Tse, G.M.K., Leung, B.C.H., Van Hasselt, C.A., Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL (2005) Cancer Journal, 11, pp. 113-121Leibovich, S.J., Polverini, P.J., Shepard, H.M., Wiseman, D.M., Shively, V., Nuseir, N., Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α (1987) Nature, 329, pp. 630-632Leitzmann, M.F., Brenner, A., Moore, S.C., Koebnick, C., Park, Y., Hollenbeck, A., Schatzkin, A., Ron, E., Prospective study of body mass index, physical activity and thyroid cancer (2010) International Journal of Cancer, 126, pp. 2947-2956Leux, C., Truong, T., Petit, C., Baron-Dubourdieu, D., Guenel, P., Family history of malignant and benign thyroid diseases and risk of thyroid cancer: A population-based case-control study in New Caledonia (2012) Cancer Causes & Control, 23, pp. 745-755